Page last updated: 2024-09-02

morpholinoanthracycline mx2 and Glioma

morpholinoanthracycline mx2 has been researched along with Glioma in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19902 (18.18)18.7374
1990's6 (54.55)18.2507
2000's3 (27.27)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kabuto, M; Kitai, R; Kobayashi, H; Kubota, T; Nakagawa, T1
Kabuto, M; Kitai, R; Kobayashi, H; Kodera, T; Kubota, T; Nakagawa, T; Uno, H1
Arai, Y; Kabuto, M; Kitai, R; Kobayashi, H; Kubota, T; Nakagawa, T1
Fujita, H; Kawamoto, K; Kiya, K; Kurisu, K; Ogasawara, H; Shinkai, H; Sugiyama, K; Uozumi, T1
Furuta, T; Matsumoto, K; Mizumatsu, S; Ohmoto, T; Ono, Y; Tamiya, T2
Arita, N; Hayakawa, T; Kuratsu, J; Kurisu, K; Uozumi, T; Ushio, Y1
Hill, JS; Kaye, AH; Park, SJ1
Mima, T; Mori, K; Mostafa, MG1
Kochi, M; Kuratsu, J; Mihara, Y; Takaki, S; Ushio, Y1
Arita, N; Hayakawa, T; Izumoto, S; Komeshima, N; Mogami, H; Ohnishi, T; Oku, Y; Taki, T; Ushio, Y; Yamamoto, H1

Trials

1 trial(s) available for morpholinoanthracycline mx2 and Glioma

ArticleYear
A phase II study of KRN8602(MX2), a novel morpholino anthracycline derivative, in patients with recurrent malignant glioma.
    Journal of neuro-oncology, 1999, Volume: 42, Issue:2

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Brain Neoplasms; Carubicin; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local

1999

Other Studies

10 other study(ies) available for morpholinoanthracycline mx2 and Glioma

ArticleYear
The antitumor effect of MX2, a new morpholino anthracycline, against malignant glioma cell lines and its subcellular distribution.
    Neurosurgery, 1995, Volume: 37, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Brain; Brain Neoplasms; Carubicin; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Glioma; Humans; Male; Microscopy, Electron; Neoplasm Transplantation; Rats; Rats, Wistar; Subcellular Fractions; Tissue Distribution; Tumor Cells, Cultured

1995
[Antitumor effect of MX2, a new morpholino anthracycline against C6 glioma cells and its combination effect with photodynamic therapy in vitro].
    No to shinkei = Brain and nerve, 1995, Volume: 47, Issue:10

    Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Glioma; Photochemotherapy; Rats; Tumor Cells, Cultured; Tumor Stem Cell Assay

1995
Subcellular localization and cellular pharmacokinetics of MX2, a new morpholino anthracycline in glioma cells using confocal laser scanning microscopy.
    Neurological research, 1994, Volume: 16, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Carubicin; Cell Line; Doxorubicin; Glioma; Humans; Male; Microscopy, Confocal; Microscopy, Electron; Rats; Rats, Wistar; Subcellular Fractions; Time Factors

1994
[Pharmacokinetics and antitumor activity of MX2, a new morpholino anthracycline in brain tumor intracerebral transplanted in rats].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Brain; Brain Neoplasms; Carubicin; Cell Division; Female; Glioma; Neoplasm Transplantation; Rats; Rats, Inbred F344; Tumor Cells, Cultured

1993
[Combination effect of hyperthermia and MX2 on cultured glioma cell lines].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Cell Survival; Coloring Agents; Combined Modality Therapy; Culture Media; Glioma; Humans; Hyperthermia, Induced; Rats; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

1999
An investigation of the cytotoxicity of the morpholino anthracycline MX2 against glioma cells in vitro.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2000, Volume: 7, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Carubicin; Cell Division; Glioma; Humans; Lipoproteins; Rats; Tumor Cells, Cultured; Tumor Stem Cell Assay

2000
Intrathecal chemotherapy with MX2 for treating glioma dissemination in vivo.
    Journal of neuro-oncology, 2000, Volume: 49, Issue:1

    Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Carubicin; Dose-Response Relationship, Drug; Feasibility Studies; Glioma; Injections, Intraventricular; Injections, Spinal; Male; Nervous System Diseases; Rats; Rats, Wistar; Survival Analysis

2000
Antitumor effect and peritumoral brain edema formation in relation to MX2, ACNU, and doxorubicin therapy: a comparative analysis using rodent models of gliomas.
    Neurological research, 2000, Volume: 22, Issue:8

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Body Weight; Brain Edema; Brain Neoplasms; Carubicin; Disease Models, Animal; Doxorubicin; Glioma; Leukocyte Count; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Nimustine; Rats; Survival Rate

2000
[Antitumor effect of a new anthracycline derivative, MX2, against human glioma cells].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:3 Pt 1

    Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Cell Line; Doxorubicin; Glioma; Humans; In Vitro Techniques; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured

1989
[Effect of MX-2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumors in rats].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Arachnoid; Brain Neoplasms; Carubicin; Female; Glioma; Humans; Meningeal Neoplasms; Naphthacenes; Pia Mater; Rats; Rats, Inbred Strains

1988